What is Prostatitis?
Prostatitis is an umbrella term encompassing infection, inflammation, or pain of the prostate gland that affects approximately 9.3% of men in their lifetime, classified into four distinct categories by the NIH that require fundamentally different diagnostic and treatment approaches 1, 2.
NIH Classification System
The NIH classification divides prostatitis into four categories 1, 2:
- Category I: Acute Bacterial Prostatitis - UTI with prostatic infection, typically with fever/chills
- Category II: Chronic Bacterial Prostatitis - Persistent bacterial infection causing recurrent UTIs
- Category III: Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) - Subdivided into IIIA (inflammatory) and IIIB (non-inflammatory), though no clinically significant differences exist between these subclasses
- Category IV: Asymptomatic Prostatitis - Incidental finding requiring no treatment
Acute Bacterial Prostatitis (Category I)
This presents as a febrile UTI with prostatic involvement. Gram-negative bacteria (E. coli, Klebsiella, Pseudomonas) cause 80-97% of cases 2. Patients present with fever, chills, and acute urinary symptoms. First-line therapy is broad-spectrum antibiotics (IV piperacillin-tazobactam, ceftriaxone, or oral ciprofloxacin) for 2-4 weeks, achieving 92-97% success rates 2.
Critical Pitfall
Overlooking acute bacterial prostatitis can lead to prostate abscess formation requiring surgical intervention, progression to chronic bacterial prostatitis requiring lifelong antibiotic management, or missing underlying diseases like malignancy 3. Always perform rectal examination in men with fever of unknown origin.
Chronic Bacterial Prostatitis (Category II)
This manifests as recurrent UTIs from the same bacterial strain, with up to 74% caused by gram-negative organisms 2. Men typically experience pain and dysuria that respond to antibiotics, remaining relatively symptom-free between infections 1.
Treatment requires minimum 4 weeks of fluoroquinolones (levofloxacin or ciprofloxacin) 2. The response rate is not high, and some patients face lifelong recurrent UTIs 3.
Diagnostic Distinction
When diagnostic uncertainty exists between chronic bacterial prostatitis and CP/CPPS, perform prostate massage with two-glass or four-glass localization testing 1. In chronic bacterial prostatitis, VB1 and VB2 cultures are negative while VB3 or expressed prostatic secretions (EPS) are positive. In CP/CPPS, all cultures are negative 1.
Chronic Prostatitis/Chronic Pelvic Pain Syndrome (Category III)
CP/CPPS is the most common form of prostatitis and represents a diagnosis of exclusion—it is NOT due to ongoing infection 1.
Defining Characteristics
Men must have pain or discomfort in the pelvic region for at least 3 months within the past 6 months without identifiable causes 1. Pain locations include:
- Perineum
- Lower abdomen/suprapubic area
- Testes
- Penis
- Pain with ejaculation or urination
Critical Clinical Insight
In real-world practice, do not rigidly apply the 3-month criterion—evaluate men with shorter symptom duration based on pain presence alone, as strict research definitions cause misdiagnosis and treatment delays 1.
Complex Pathophysiology
CP/CPPS involves a complex interplay of multiple systems, not just the prostate 1:
- 75% have bladder symptoms including pain with bladder filling and painful urge to urinate
- 70% report pain outside the pelvis
- Chronic overlapping pain conditions are common: IBS (34%), migraine (24%), fibromyalgia (13%), chronic fatigue syndrome (5%)
- Pelvic floor muscle dysfunction is present—men with CP/CPPS have more difficulty relaxing pelvic floor muscles than controls
- Higher rates of depression and anxiety correlate with greater symptom severity
Essential Physical Examination
Perform digital transrectal palpation of pelvic floor muscles to identify tenderness of the anterior levator ani, posterior levator ani, and obturator internus muscles, plus external palpation of the perineal body 1. This identifies pelvic floor myalgia, a key component.
Confusable Disorders to Exclude
CP/CPPS is diagnosed only after excluding 1:
- UTI (by standard culture methods)
- Urogenital cancer
- Prior radiation/chemotherapy
- Urethral stricture
- Neurologic disease affecting bladder
- Bladder outlet obstruction
- Urinary retention
Pelvic pain distinguishes CP/CPPS from benign prostatic hyperplasia (which presents with LUTS without pain) and overactive bladder (urgency/frequency without pain) 1.
Treatment Approach
For CP/CPPS with voiding symptoms, offer alpha-blockers (tamsulosin, alfuzosin) as first-line therapy 4, 2. The NIH-CPSI score difference versus placebo ranges from -10.8 to -4.8 points (6-point change is clinically meaningful) 2.
Other therapies show modest benefit 2:
- Anti-inflammatory drugs (ibuprofen): ΔNIH-CPSI -2.5 to -1.7
- Pregabalin: ΔNIH-CPSI -2.4
- Pollen extract: ΔNIH-CPSI -2.49
A multimodal/multidisciplinary approach is recommended 1, 4, addressing cardiovascular, psychological, immunological, neurologic, musculoskeletal, and endocrine factors.
Testing Caveats
Do NOT routinely send urine for atypical organism cultures or next-generation sequencing for bacterial DNA 1. However, perform nucleic acid amplification testing for gonorrhea, chlamydia, trichomonas, and mycoplasma genitalium if STD is suspected (sexual exposure, urethral discharge, prior history) 1.
Semen culture has no role in CP/CPPS diagnosis 1.
Asymptomatic Prostatitis (Category IV)
This is an incidental finding during workup for other urologic conditions and requires no treatment 5.